DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Dopamine Hydrochloride In Dextrose 5% In Plastic Container patents expire, and when can generic versions of Dopamine Hydrochloride In Dextrose 5% In Plastic Container launch?
Dopamine Hydrochloride In Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and Hospira and is included in two NDAs.
The generic ingredient in DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dopamine Hydrochloride In Dextrose 5% In Plastic Container
A generic version of DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.
Summary for DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Clinical Trials: | 996 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prof. Dr. Stefan M. Gold | N/A |
Dr. Ulrike Grittner | N/A |
Virginia Commonwealth University | Phase 2 |
See all DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
Pharmacology for DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug Class | Catecholamine |